Hepatitis C (HCV) and Hepatitis B (HBV)

2.4 million people are estimated to be living with hepatitis C in the United States. The actual number may be as high as 4.7 million or as low as 2.5 million. 850,000 people in the U.S. are estimated to be living with hepatitis B.

Acute hepatitis C infection is often asymptomatic, but >50% of cases will progress to chronic infection, which can be life-threatening. Hepatitis C can be diagnosed with a blood test and is curable. The annual rate of reported acute hepatitis C tripled from 2009 to 2018 and was highest among persons aged 20–39 years. In 2018, the largest proportion of chronic hepatitis C cases occurred among persons aged 20–39 years and 50–69 years. Only 61% of adults with hepatitis C knew that they were infected.

New data show that chronic hepatitis C infection affects every generation—underscoring new CDC recommendations that every adult should be tested at least once in their lifetime for this curable infection. Previously, hepatitis C was primarily a concern for the baby boomer generation, as well as people with risk factors, such as injection drug use. (Source: Centers for Disease Control)

Virtual State Policy Roundtable: Hepatitis C Treatment and Elimination in Washington State
Hosted by:
WA State Representative Cindy Ryu
Michael Ninburg, Executive Director, Hepatitis Education Project (HEP)
Sue Birch, Director, Washington Health Care Authority

Resources for Hepatitis C and Hepatitis B

Hepatitis C

  • Hepatitis Education Project The Hepatitis Education Project is committed to improving health of underserved communities disproportionately impacted by viral hepatitis. (http://www.hepeducation.org/)

  • World Hepatitis Alliance The world hepatitis alliance runs global campaigns, convenes high-level policy events, builds capacity and pioneers global movements, ensuring people living with viral hepatitis guide every aspect of their work. (https://www.worldhepatitisalliance.org/)

Hepatitis B